Search by Drug Name or NDC
NDC 41250-0812-30 mucus dm 60; 1200 mg/1; mg/1 Details
mucus dm 60; 1200 mg/1; mg/1
mucus dm is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Meijer Distribution Inc. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 41250-0812-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 41250-0812-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
| NDC | 41250-0812 |
|---|---|
| Product ID | 41250-812_881f88a1-11db-47b1-bd0d-b0f1ed602cf5 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | mucus dm |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | dextromethorphan HBr, guaifenesin |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 60; 1200 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
| Labeler Name | Meijer Distribution Inc |
| Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207602 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 41250-0812-30 (41250081230)
| NDC Package Code | 41250-812-30 |
|---|---|
| Billing NDC | 41250081230 |
| Package | 1 BOTTLE in 1 CARTON (41250-812-30) / 28 TABLET, EXTENDED RELEASE in 1 BOTTLE |
| Marketing Start Date | 2018-08-08 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |